α-Synuclein- and MPTP-Generated Rodent Models of Parkinson's Disease and the Study of Extracellular Striatal Dopamine Dynamics: A Microdialysis Approach

被引:32
作者
Bazzu, Gianfranco [1 ]
Calia, Giammario [1 ]
Puggioni, Giulia [1 ]
Spissu, Ylenia [1 ]
Rocchitta, Gaia [1 ]
Debetto, Patrizia [2 ]
Grigoletto, Jessica [2 ]
Zusso, Morena [2 ]
Migheli, Rossana [1 ]
Serra, Pier Andrea [1 ]
Desole, Maria Speranza [1 ]
Miele, Egidio [1 ]
机构
[1] Univ Sassari, Dept Neurosci, Sch Med, I-07100 Sassari, Italy
[2] Univ Padua, Dept Pharmacol & Anesthesiol, I-35131 Padua, Italy
关键词
Parkinson's disease; alpha-synuclein; 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; dopamine; microdialysis; ascorbic acid; FREELY MOVING RATS; IN-VITRO; ENDOGENOUS MELATONIN; SIGNALING PATHWAYS; NITRIC-OXIDE; MOUSE MODEL; PC12; CELLS; MUTATIONS; NEUROTOXICITY; PATHOGENESIS;
D O I
10.2174/187152710791556177
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The classical animal models of Parkinson's disease (PD) rely on the use of neurotoxins, including 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), 6-hydroxydopamine and, more recently, the agricultural chemicals paraquat and rotenone, to deplete dopamine (DA). These neurotoxins elicit motor deficits in different animal species although MPTP fails to induce a significant dopaminergic neurodegeneration in rats. In the attempt to better reproduce the key features of PD, in particular the progressive nature of neurodegeneration, alternative PD models have been developed, based on the genetic and neuropathological links between alpha-synuclein (alpha-syn) and PD. In vivo microdialysis was used to investigate extracellular striatal DA dynamics in MPTP- and alpha-syn-generated rodent models of PD. Acute and sub-acute MPTP intoxication of mice both induce prolonged release of striatal DA. Such DA release may be considered the first step in MPTP-induced striatal DA depletion and nigral neuron death, mainly through reactive oxygen species generation. Although MPTP induces DA reduction, neurochemical and motor recovery starts immediately after the end of treatment, suggesting that compensatory mechanisms are activated. Thus, the MPTP mouse model of PD may be unsuitable for closely reproducing the features of the human disease and predicting potential long-term therapeutic effects, in terms of both striatal extracellular DA and behavioral outcome. In contrast, the alpha-syn-generated rat model of PD does not suffer from a massive release of striatal DA during induction of the nigral lesion, but rather is characterized by a prolonged reduction in baseline DA and nicotine-induced increases in dialysate DA levels. These results are suggestive of a stable nigrostriatal lesion with a lack of dopaminergic neurochemical recovery. The alpha-syn rat model thus reproduces the initial stage and slow development of PD, with a time-dependent impairment in motor function. This article will describe the above experimental PD models and demonstrate the utility of microdialysis for their characterization.
引用
收藏
页码:482 / 490
页数:9
相关论文
共 74 条
  • [11] Couzin J, 2001, SCIENCE, V294, P1257
  • [12] Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for mitochondrial complex I activity
    Dabbeni-Sala, F
    Di Santo, S
    Franceschini, D
    Skaper, SD
    Giusti, P
    [J]. FASEB JOURNAL, 2001, 15 (01) : 164 - 170
  • [13] Animal models of PD: Pieces of the same puzzle?
    Dawson, TM
    Mandir, AS
    Lee, MK
    [J]. NEURON, 2002, 35 (02) : 219 - 222
  • [14] Dluzen D E, 2000, J Gend Specif Med, V3, P36
  • [15] George JM, 2002, GENOME BIOL, V3
  • [16] Gerlach M, 2006, J NEURAL TRANSM-SUPP, P133
  • [17] Alpha-synuclein and neurodegenerative diseases
    Goedert, M
    [J]. NATURE REVIEWS NEUROSCIENCE, 2001, 2 (07) : 492 - 501
  • [18] Clinical and quantitative pathologic correlates of dementia with Lewy bodies
    Gómez-Tortosa, E
    Newell, K
    Irizarry, MC
    Albert, M
    Growdon, JH
    Hyman, BT
    [J]. NEUROLOGY, 1999, 53 (06) : 1284 - 1291
  • [19] The E46K mutation in α-synuclein increases amyloid fibril formation
    Greenbaum, EA
    Graves, CL
    Mishizen-Eberz, AJ
    Lupoli, MA
    Lynch, DR
    Englander, SW
    Axelsen, PH
    Giasson, BI
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (09) : 7800 - 7807
  • [20] THE PRECURSOR PROTEIN OF NON-A-BETA COMPONENT OF ALZHEIMERS-DISEASE AMYLOID IS A PRESYNAPTIC PROTEIN OF THE CENTRAL-NERVOUS-SYSTEM
    IWAI, A
    MASLIAH, E
    YOSHIMOTO, M
    GE, NF
    FLANAGAN, L
    DESILVA, HAR
    KITTEL, A
    SAITOH, T
    [J]. NEURON, 1995, 14 (02) : 467 - 475